Evaluating the Role of the Gabrin Sign in Predicting COVID-19 Severity Among Patients with Androgenic Alopecia

This study investigates the link between androgenic alopecia (AGA) and COVID-19 severity, finding a strong association between higher grades of AGA and increased COVID-19 mortality. Conducted on 379 ICU patients with confirmed COVID-19, the study reveals that males with severe AGA (Hamilton–Norwood Scale grades 5–7) had a 16.1% mortality rate, while females with severe AGA (Ludwig Scale Grade 3) had a 12.3% mortality rate, both higher than the general mortality rates of 10.1% for males and 9.3% for females. The study suggests that androgen activity may be a risk factor for severe COVID-19, highlighting the need for further research into androgen-targeted therapies.